Here’s a striking update from March 2024: researchers found that metformin, a widely used diabetes drug, increases production of lac‑Phe — a molecule that lowers hunger. The result? Reduced appetite and measurable weight loss in study subjects. That finding shifts how we think about metformin: not just blood sugar control, but a possible tool in obesity research.
Scientists measured lac‑Phe levels after metformin use and saw a clear rise. In lab and early human data, higher lac‑Phe was linked to less food intake and weight drop. Mechanistically, metformin appears to change how muscles and liver handle lactate and amino acids, which boosts lac‑Phe formation. That molecule then seems to act on brain pathways that blunt hunger signals.
This isn’t magic — the weight loss reported so far was real but moderate. The work is promising because it points to a defined biochemical route for appetite control, which could be targeted more precisely in the future.
If you take metformin for diabetes, this finding helps explain why some people lose weight on it. If you’re thinking of taking metformin solely to lose weight, talk with your doctor first. Metformin is a prescription drug with side effects and interactions. Doctors will weigh benefits, existing conditions, and other meds before prescribing it off‑label.
Researchers are already looking at two directions: using metformin’s impact on lac‑Phe to design new obesity drugs that act directly on that pathway, and running bigger clinical trials to see how consistent the effect is across diverse groups. That means safer, more targeted options could appear in the next few years — but not overnight.
Practically speaking, there are three things to remember: 1) This discovery adds a clear biological reason why metformin can lower appetite. 2) Current evidence supports cautious optimism, not immediate clinical change. 3) Lifestyle steps — diet, exercise, sleep — remain the proven foundation for weight control while science tests drug-based options.
Want to follow this topic? Watch for larger clinical trials and announcements from diabetes and obesity research centers. If you’re managing weight or diabetes now, bring this study up with your clinician to see whether any change in treatment makes sense for your situation.
March 2024’s coverage on MarleyDrug highlights a concrete, testable mechanism behind metformin’s effects. That’s the kind of finding that moves treatment ideas from guesswork into targeted research — and it’s worth paying attention to as the next round of studies arrives.
Recent research has uncovered that Metformin, a diabetes medication, significantly increases the production of an 'anti-hunger' molecule, lac-phe, leading to reduced appetite and significant weight loss. This discovery opens new avenues for obesity treatment, showcasing Metformin's potential beyond diabetes management.
© 2025. All rights reserved.
